Tilray Executive and Leadership Team

Irwin Simon, the Chairman & Chief Executive Officer at Tilray, directs the overarching corporate strategy for medical cannabis research and production. Overseeing the integration of diverse pharmaceutical assets, the Chairman & Chief Executive Officer ensures alignment between cultivation output and global market demand. This leadership role involves constant engagement with the Board to refine long-term growth trajectories and operational efficiency. By prioritizing innovation in cannabinoid science, Irwin Simon directly impacts the competitive positioning of the organization within the North American and European sectors. Through rigorous oversight of production standards, the Chairman & Chief Executive Officer maintains the integrity of the supply chain. Ultimately, Simon secures the financial and operational health of the enterprise while driving expansion into emerging medical markets, ensuring the company remains at the forefront of the pharmaceutical industry.

Carl Merton, the Chief Financial Officer at Tilray, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial reporting and investor relations, the Chief Financial Officer ensures transparency and compliance within the pharmaceutical manufacturing sector. This leadership role involves analyzing market trends to guide investment in research and development, directly impacting the company's ability to scale production. By optimizing the balance sheet, Carl Merton supports the long-term sustainability of the business model. Merton collaborates with the executive team to evaluate potential acquisitions and regional expansion opportunities, ensuring fiscal discipline across all operations. Through the implementation of rigorous financial controls, the Chief Financial Officer mitigates risk while maximizing shareholder value. Ultimately, Merton provides the economic foundation required to sustain the company's mission of advancing medical cannabinoid distribution on a global scale.

Blair MacNeil, the President, Canada at Tilray, executes the strategic vision for the company's primary market operations. Overseeing the cultivation, production, and distribution of medical cannabis within the domestic landscape, the President, Canada ensures adherence to strict regulatory frameworks. This leadership role involves managing local supply chains and optimizing manufacturing output to meet the specific needs of the Canadian healthcare sector. By driving regional initiatives, Blair MacNeil directly contributes to the company's market share and brand reputation. MacNeil collaborates with the executive team to align domestic production goals with global corporate objectives. Through the management of local partnerships and distribution channels, the President, Canada secures the company's position as a leader in the pharmaceutical industry. Ultimately, MacNeil ensures that the Canadian operations remain a cornerstone of the company's success, providing consistent, high-quality cannabinoid products to patients across the region.

Lloyd Brathwaite, the Chief Information Officer at Tilray, architects the digital infrastructure supporting global cannabis cultivation and distribution networks. Managing complex data systems, the Chief Information Officer ensures secure, real-time tracking of pharmaceutical inventory across international borders. This leadership role involves implementing advanced analytics to optimize production yields and supply chain transparency. By modernizing the technological framework, Lloyd Brathwaite directly supports the scalability of the company's medical cannabis operations. Brathwaite coordinates with other C-suite leaders to integrate digital solutions into the broader business model, enhancing operational agility. Through the deployment of robust cybersecurity protocols, the Chief Information Officer protects sensitive research data and proprietary cultivation methodologies. Ultimately, Brathwaite drives the digital transformation necessary to maintain a competitive edge in the highly regulated pharmaceutical manufacturing landscape, ensuring seamless connectivity across all regional facilities.

Roger Savell, the Chief Administrative Officer at Tilray, directs the internal operational processes and organizational governance required for pharmaceutical manufacturing. Overseeing human resources, legal compliance, and facility management, the Chief Administrative Officer ensures that all corporate functions align with the company's mission of medical cannabis production. This leadership role involves streamlining administrative workflows to enhance productivity across diverse regional sites. By fostering a culture of operational excellence, Roger Savell directly supports the efficiency of the cultivation and distribution teams. Savell coordinates with the Board to implement governance policies that meet international regulatory standards. Through the management of corporate infrastructure, the Chief Administrative Officer provides the necessary support for the company's growth initiatives. Ultimately, Savell maintains the organizational stability required to navigate the complexities of the global cannabis industry, ensuring all departments operate in harmony with the broader corporate strategy.